10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 267 filers reported holding 10X GENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $230,075,821 | +10.3% | 4,120,269 | +10.2% | 0.71% | +3.9% |
| Q1 2023 | $208,530,077 | +178352.0% | 3,737,768 | +16.6% | 0.69% | +55.8% |
| Q4 2022 | $116,855 | -99.9% | 3,206,783 | -5.4% | 0.44% | +21.8% |
| Q3 2022 | $96,581,000 | -39.5% | 3,391,177 | -3.8% | 0.36% | -34.4% |
| Q2 2022 | $159,591,000 | -34.5% | 3,526,878 | +10.2% | 0.55% | -1.4% |
| Q1 2022 | $243,530,000 | -1.7% | 3,201,394 | +92.4% | 0.56% | +21.7% |
| Q4 2021 | $247,865,000 | – | 1,663,967 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 3,500,000 | $312,585,000 | 98.53% |
| Venrock Management VI, LLC | 9,344,551 | $834,562,000 | 96.64% |
| Foresite Capital Management II, LLC | 5,503,528 | $491,520,000 | 96.63% |
| FINANCIAL CONSULATE, INC | 196,938 | $17,589,000 | 8.94% |
| JS Capital Management LLC | 1,062,763 | $94,915,000 | 7.17% |
| 12 West Capital Management LP | 1,435,000 | $128,160,000 | 6.62% |
| Asymmetry Capital Management, L.P. | 50,819 | $4,539,000 | 3.48% |
| CAAS CAPITAL MANAGEMENT LP | 547,916 | $48,934,000 | 1.61% |
| RTW INVESTMENTS, LP | 636,092 | $56,809,000 | 1.60% |
| SB INVESTMENT ADVISERS (UK) LTD | 1,639,901 | $146,460,000 | 1.60% |